Project Details
Description
Q32 Bio Inc. Primary Funding Source: 2. Proposal Title: A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Clinical Activity of ADX-097 Administered Subcutaneously in Male and Female Participants Aged 18 Years or Older With
| Status | Active |
|---|---|
| Effective start/end date | 3/28/24 → 3/31/34 |
Funding
- Q32 BIO INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.